Aimed Bio Statistics

Total Valuation

Aimed Bio has a market cap or net worth of KRW 3.16 trillion. The enterprise value is 2.99 trillion.

Market Cap	3.16T
Enterprise Value	2.99T

Important Dates

The last earnings date was Monday, April 13, 2026.

Earnings Date	Apr 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Aimed Bio has 64.67 million shares outstanding. The number of shares has increased by 39.98% in one year.

Current Share Class	64.67M
Shares Outstanding	64.67M
Shares Change (YoY)	+39.98%
Shares Change (QoQ)	+34.68%
Owned by Insiders (%)	34.37%
Owned by Institutions (%)	10.39%
Float	22.61M

Valuation Ratios

The trailing PE ratio is 629.00 and the forward PE ratio is 287.35.

PE Ratio	629.00
Forward PE	287.35
PS Ratio	66.82
PB Ratio	16.41
P/TBV Ratio	16.54
P/FCF Ratio	180.46
P/OCF Ratio	176.88
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 134.96, with an EV/FCF ratio of 170.77.

EV / Earnings	595.22
EV / Sales	63.23
EV / EBITDA	134.96
EV / EBIT	143.94
EV / FCF	170.77

Financial Position

The company has a current ratio of 31.43, with a Debt / Equity ratio of 0.01.

Current Ratio	31.43
Quick Ratio	31.17
Debt / Equity	0.01
Debt / EBITDA	0.05
Debt / FCF	0.07
Interest Coverage	364.15

Financial Efficiency

Return on equity (ROE) is 4.23% and return on invested capital (ROIC) is 10.86%.

Return on Equity (ROE)	4.23%
Return on Assets (ROA)	10.55%
Return on Invested Capital (ROIC)	10.86%
Return on Capital Employed (ROCE)	10.74%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.38
Inventory Turnover	n/a

Taxes

Income Tax	-9.18B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	53,589.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.83
Average Volume (20 Days)	201,780

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aimed Bio had revenue of KRW 47.28 billion and earned 5.02 billion in profits. Earnings per share was 101.00.

Revenue	47.28B
Gross Profit	47.28B
Operating Income	20.77B
Pretax Income	-4.16B
Net Income	5.02B
EBITDA	22.15B
EBIT	20.77B
Earnings Per Share (EPS)	101.00

Full Income Statement

Balance Sheet

The company has 170.83 billion in cash and 1.16 billion in debt, giving a net cash position of 169.66 billion or 2,623.48 per share.

Cash & Cash Equivalents	170.83B
Total Debt	1.16B
Net Cash	169.66B
Net Cash Per Share	2,623.48
Equity (Book Value)	192.57B
Book Value Per Share	3,208.15
Working Capital	172.84B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.86 billion and capital expenditures -353.69 million, giving a free cash flow of 17.51 billion.

Operating Cash Flow	17.86B
Capital Expenditures	-353.69M
Depreciation & Amortization	1.38B
Net Borrowing	-538.39M
Free Cash Flow	17.51B
FCF Per Share	270.70

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 43.93% and 10.62%.

Gross Margin	100.00%
Operating Margin	43.93%
Pretax Margin	-8.81%
Profit Margin	10.62%
EBITDA Margin	46.85%
EBIT Margin	43.93%
FCF Margin	37.03%

Dividends & Yields

Aimed Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.98%
Shareholder Yield	-39.98%
Earnings Yield	0.16%
FCF Yield	0.55%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6